RxDoctor Payments Data

Barbara Michael, MD

Family Medicine · Greensboro, NCNPI 1962616789

Payments from drug & device makers

$2,036in general payments, 2019–2025

Across 107 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$386
  • Lilly USA, LLC$307
  • Otsuka America Pharmaceutical, Inc.$148
  • Dynavax Technologies Corporation$122
  • Boehringer Ingelheim$95
  • Exact Sciences$92
  • plus $885 from 23 others

What the payments were for

  • Food & beverage$2,036100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,036 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$40,951
Medicare patients
123
Services billed
2,214

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$54,206
EliquisApixaban30$29,064
RybelsusSemaglutide17$25,728
JardianceEmpagliflozin20$22,937
MyrbetriqMirabegron15$12,595
MounjaroTirzepatide12$12,393
FarxigaDapagliflozin Propanediol11$8,617
SynthroidLevothyroxine Sodium20$2,498
Atorvastatin Calcium207$2,413
Rosuvastatin Calcium178$2,178
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen45$1,956
Telmisartan36$1,808
Omeprazole85$1,544
Fluticasone Propionate72$1,339
Levothyroxine Sodium135$1,330

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$386$79,93464 claims
PfizerEliquis$67$29,06430 claims
Boehringer IngelheimJardiance$95$22,93720 claims
Lilly USA, LLCMounjaro$307$12,39312 claims
AstraZenecaFarxiga$84$8,61711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →